A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales

BACKGROUND: Postnatal and antenatal anti-D prophylaxis have dramatically reduced maternal sensitisations and cases of rhesus disease in babies born to women with RhD negative blood group. Recent scientific advances mean that non-invasive prenatal diagnosis (NIPD), based on the presence of cell-free...

Descripción completa

Detalles Bibliográficos
Autores principales: Szczepura, Ala, Osipenko, Leeza, Freeman, Karoline
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034710/
https://www.ncbi.nlm.nih.gov/pubmed/21244652
http://dx.doi.org/10.1186/1471-2393-11-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034710/
https://www.ncbi.nlm.nih.gov/pubmed/21244652
http://dx.doi.org/10.1186/1471-2393-11-5

Ejemplares similares